Clinical Trial Update: Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

View source ↗

Summary

Clinical trial update on treatment with bempedoic acid and its fixed-dose combination with ezetimibe for primary hypercholesterolemia and mixed dyslipidemia. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• NEXLIZET (bempedoic acid and ezetimibe)
• Nexletol (bempedoic acid)

Snippet

Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | Conditions: Hypercholesterolemia, Mixed Dyslipidemia | Status: ACTIVE_NOT_RECRUITING